Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Stefania Greco, Giovanni Delli Carpini, Abel Duménigo González, Gaia Goteri, Andrea Ciavattini, Pasquapina Ciarmela
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prevalence, wellbeing, and symptoms of dysmenorrhea among university nursing students in Greece
10.3390/diseases7010005 · 2019
Primary dysmenorrhea: diagnosis and therapy
10.1097/aog.0000000000004096 · 2020
Diagnosis and management of primary dysmenorrhea
10.1001/jama.2019.16921 · 2020
Efficacy of chamomile in the treatment of premenstrual syndrome: a systematic review
10.3831/kpi.2019.22.028 · 2019
Dysmenorrhea and its effects on school absenteeism and school activities among adolescents in selected secondary schools in Ibadan, Nigeria
10.4103/nmj.nmj_47_17 · 2017
Dysmenorrhea prevalence among adolescents in eastern Turkey: its effects on school performance and relationships with family and friends
10.1016/j.jpag.2010.02.009 · 2010
No. 345-primary dysmenorrhea consensus guideline
10.1016/j.jogc.2016.12.023 · 2017
What we know about primary dysmenorrhea today: a critical review
10.1093/humupd/dmv039 · 2015
Unresolved referenced work
2025
Dysmenorrhea and related disorders
10.12688/f1000research.11682.1 · 2017
WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity
10.1186/1471-2458-6-177 · 2006
Primary dysmenorrhea: advances in pathogenesis and management
10.1097/01.aog.0000230214.26638.0c · 2006
Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility
10.3109/00016347909157790 · 1979
Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the development of endometriosis
10.2217/whe.12.52 · 2012
Prostaglandin receptors are mediators of vascular function in endometrial pathologies
10.1016/j.mce.2006.03.025 · 2006
Influence of menstrual factors and dietary habits on menstrual pain in adolescence age
10.1016/s0301-2115(99)00277-8 · 2000
Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women
10.1016/0002-9378(78)90320-4 · 1978
Dysmenorrhoea among Hong Kong university students: prevalence, impact, and management
2013
Primary dysmenorrhoea in adolescents and young women: a twin family study of maternal transmission, genetic influence and associations
10.1111/ajo.13560 · 2022
The BDNF Val66Met polymorphism is associated with the functional connectivity dynamics of pain modulatory systems in primary dysmenorrhea
10.1038/srep23639 · 2016
Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies
10.1517/14656566.2012.725045 · 2012
Prevalence of menstrual pain in young women: what is dysmenorrhea?
10.2147/jpr.s30602 · 2012
Stress and dysmenorrhoea: a population based prospective study
10.1136/oem.2003.012302 · 2004
Oral contraceptive pill for primary dysmenorrhoea
10.1002/14651858.cd002120.pub2 · 2009
Dysmenorrhea, a narrative review of therapeutic options
10.2147/jpr.s459584 · 2024
Quality of life by dysmenorrhea severity in young and adult Japanese females: a web-based cross-sectional study
10.1371/journal.pone.0283130 · 2023
Quality of patient-reported outcome measures for primary dysmenorrhea: a systematic review
10.1007/s11136-023-03517-8 · 2024
ESHRE guideline: endometriosis
10.1093/hropen/hoac009 · 2022
Comorbid pain experiences in young women with dysmenorrhea
10.1080/03630242.2020.1781741 · 2020
Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment
10.1016/j.ajog.2017.08.108 · 2018
Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea
10.1002/14651858.cd001751 · 2003
The treatment of dysmenorrhea
10.1016/j.pcl.2016.11.004 · 2017
Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review
10.1111/j.1471-0528.1998.tb10210.x · 1998
Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives
10.1016/s1083-3188(00)00076-0 · 2001
Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates
10.4082/kjfm.21.0103 · 2022
Investigating cardiovascular risk in premenopausal women on oral contraceptives: systematic review with meta-analysis
10.3389/fcvm.2023.1127104 · 2023
Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial
10.1097/aog.0b013e318257217a · 2012
Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis
10.1111/jth.13349 · 2016
U.S. Medical eligibility criteria for contraceptive use, 2024
10.15585/mmwr.rr7304a1 · 2024
How effective are non-drug, non-surgical treatments for primary dysmenorrhoea?
10.1136/bmj.e3011 · 2012
Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies
10.1016/j.thromres.2015.04.021 · doi-reference
Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database
10.1016/j.contraception.2021.01.010 · doi-reference
The contraindications to combined oral contraceptives among reproductive-aged women in an obstetrics and gynaecology clinic: a single-centre cross-sectional study
10.3390/ijerph19031567 · doi-reference
The efficacy of zinc administration in the treatment of primary dysmenorrhea
10.5001/omj.2016.21 · doi-reference
Efficacy of zinc supplementation for the treatment of dysmenorrhoea: a double-blind randomised controlled trial
10.1177/03000605231171489 · doi-reference
The effects of vitamin E on the intensity of primary dysmenorrhea: a systematic review and meta-analysis
10.1016/j.clnesp.2022.10.001 · doi-reference
A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea
10.1111/j.1471-0528.2004.00495.x · doi-reference
Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis
10.1093/nutrit/nuz023 · doi-reference
Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus)
10.1016/j.phymed.2010.11.013 · doi-reference
Crocus sativus (saffron) petals extract and its active ingredient, anthocyanin improves ovarian dysfunction, regulation of inflammatory genes and antioxidant factors in testosterone-induced PCOS mice
10.1016/j.jep.2021.114594 · doi-reference
Herbal treatments for alleviating premenstrual symptoms: a systematic review
10.3109/0167482x.2010.538102 · doi-reference
Saffron extract as an emerging novel therapeutic option in reproduction and sexual health: recent advances and future prospectives
10.1097/ms9.0000000000002013 · doi-reference
Effects of adlay (Coix lachryma-jobi L. var. Ma-yuen Stapf.) hull extracts on the secretion of progesterone and estradiol in vivo and in vitro
10.3181/0612-rm-306 · doi-reference
Isolation and identification of anti-inflammatory and analgesic polysaccharides from Coix seed (Coix lacryma-jobi L. var. Ma-yuen (Roman.) Stapf)
10.1080/14786419.2022.2162896 · doi-reference
Opioidergic mechanisms underlying the actions of Vitex agnus-castus L
10.1016/j.bcp.2010.09.013 · doi-reference
Use of Vitex agnus-castus in patients with menstrual cycle disorders: a single-center retrospective longitudinal cohort study
10.1007/s00404-023-07363-4 · doi-reference
The effect of aromatherapy alone or in combination with massage on dysmenorrhea: a systematic review and meta-analysis
10.1055/s-0041-1740210 · doi-reference
Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: a double blinded randomized crossover study
10.4103/1735-9066.185574 · doi-reference
The health benefits of blackcurrants
10.1039/c2fo30058c · doi-reference
The effects of blueberry phytochemicals on cell models of inflammation and oxidative stress
10.1093/advances/nmab137 · doi-reference
Active compounds in fruits and inflammation in the body
10.3390/nu14122496 · doi-reference
Relationship between diet, menstrual pain and other menstrual characteristics among Spanish students
10.3390/nu12061759 · doi-reference
Efficacy of herbal medicine (cinnamon/fennel/ginger) for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials
10.1177/0300060520936179 · doi-reference
The effect of Cinnamon on primary dysmenorrhea: a randomized, double-blind clinical trial
10.1016/j.ctcp.2018.08.001 · doi-reference
Liposomal mineral absorption: a randomized crossover trial
10.3390/nu14163321 · doi-reference
Chronic organic magnesium supplementation enhances tissue-specific bioavailability and functional capacity in rats: a focus on brain, muscle, and vascular health
10.1007/s12011-025-04678-y · doi-reference
Effectiveness of magnesium on menstrual symptoms among dysmenorrheal college students: a randomized controlled trial
10.15296/ijwhr.2023.25 · doi-reference
Effect of turmeric-Boswellia-sesame formulation in menstrual cramp pain associated with primary dysmenorrhea-a double-blind, randomized, placebo-controlled study
10.3390/jcm12123968 · doi-reference
Effect of curcumin on dysmenorrhea and symptoms of premenstrual syndrome: a systematic review and meta-analysis
10.4082/kjfm.23.0184 · doi-reference
Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea
10.1089/acm.2008.0311 · doi-reference
Clinical trials on pain lowering effect of ginger: a narrative review
10.1002/ptr.6730 · doi-reference
Effect of Zingiber officinale R. Rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial
10.1186/1472-6882-12-92 · doi-reference
Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: systematic literature review and meta-analysis
10.1111/1747-0080.12835 · doi-reference
Omega-3 fatty acids and inflammatory processes
10.3390/nu2030355 · doi-reference
Effect of omega-3 fatty acids on intensity of primary dysmenorrhea
10.1016/j.ijgo.2011.11.019 · doi-reference
The anti-inflammatory and antioxidant properties of n-3 PUFAs: their role in cardiovascular protection
10.3390/biomedicines8090306 · doi-reference
Saffron (Crocus sativus) and its constituents for pain management: a review of current evidence
10.1002/ptr.7968 · doi-reference
Saffron for the management of premenstrual dysphoric disorder: a randomized controlled trial
10.4103/abr.abr_49_20 · doi-reference
Impact of adlay-based formula on pain and discomfort in women with dysmenorrhea: a randomized controlled trial
10.3390/nu16234026 · doi-reference
Omega-3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells
10.1002/jcp.26537 · doi-reference